Perspective from Christina Lindenmeyer, MD
Source:

Healio Interview

Disclosures: Flamm reports no relevant financial disclosures.
April 05, 2022
1 min watch
Save

VIDEO: New interventions may soon treat alcohol-related hepatitis, expert says

Perspective from Christina Lindenmeyer, MD
Source:

Healio Interview

Disclosures: Flamm reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio video exclusive, Steven L. Flamm, MD, chief of the hepatology program at Northwestern Feinberg School of Medicine, discusses the rise in alcohol-related hepatitis during COVID-19, as well as promising new treatment options.

April is Alcohol Awareness Month, and Flamm, who also is professor of medicine at Northwestern, detailed symptoms of alcohol-related hepatitis, which may include marked fatigue, jaundice, upper gastrointestinal bleeding, massive swelling and reduced mentation. The mortality rate with an acute presentation — even in young patients — can exceed 50% in 1 to 3 months.

According to Flamm, alcohol-related hepatitis is very common, and rates dramatically increased during the COVID-19 pandemic, which may have resulted from relationship, work, medical or financial stress.

Flamm noted that there are not many therapeutic options available for patients with alcohol-related hepatitis, and corticosteroids have limited efficacy. However, new therapeutics are currently being investigated, and some have shown promise in early trials.

“We continue to be hopeful that this active research program will lead to new interventions that are efficacious and safe for patients that have alcohol-related hepatitis, because it is a very, very serious unmet medical need,” Flamm said.